XAGE Stock Price, Chart, Stats & News

Longevity Health Holdings Inc.
Save
Longevity Health Holdings Inc. (XAGE) does not currently pay a dividend.
317,372
Market cap
–
Current P/E
–
Forward P/E
XAGE chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Longevity Health Holdings Inc. specializes in creating plasma-based bioactive materials (PBMs) aimed at fostering tissue regeneration and repair in response to injury, illness, and the natural aging process. The company's primary investigational product is CT-101, which acts as a powerful accelerant for bone healing in diverse applications such as tibia fracture recovery, foot/ankle and spinal fusions, serving as a dental bone graft substitute, and filling bone voids. Additionally, CT-101 functions as a tissue healing accelerant, offering potential for treating androgenetic alopecia and persistent chronic wounds.
Similar securities
Based on sector and market capitalization
Report issue





